Pan-lyssavirus vaccines against rabies

Pan-lyssavirus vaccines against rabies

  • CN 103,068,985 A
  • Filed: 06/23/2011
  • Published: 04/24/2013
  • Est. Priority Date: 06/24/2010
  • Status: Active Application
First Claim
Patent Images

1. recombinant rabies virus, wherein, the genome of described rabies virus comprises RVNP (N), phosphorprotein (P), stromatin (M), the gene of RNA RNA-dependent polysaccharase (L) and glycoprotein (G) and at least two different allos lyssavirus viral glycoprotein genes, wherein said lyssavirus virus is selected from Lagos bat viruses (LBV), not carat viral (MOKV), Du Wenhaige virus (DUVV), Europe bat rabies virus-1(EBLV-1), Europe bat rabies virus-2(EBLV-2), Australia bat rabies virus (ABLV), Aravan virus (ARAV), Khujand virus (KHUV), Irkut virus (IRKV) and western Caucasia bat viruses (WCBV).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×